Terms: = Endocrine gland cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
27 results:
1. Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
Luo L; Xu N; Liu Y; Zhong S; Yang S; Chen X
Int J Gynaecol Obstet; 2024 Apr; 165(1):176-187. PubMed ID: 38013509
[TBL] [Abstract] [Full Text] [Related]
2. Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study.
Kirkegård J; Cronin-Fenton D; Lund A; Mortensen FV
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5726. PubMed ID: 37946571
[TBL] [Abstract] [Full Text] [Related]
3. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
4. Intraductal tubulopapillary neoplasms of the bile ducts: identity, clinicopathologic characteristics, and differential diagnosis of a distinct entity among intraductal tumors.
Pehlivanoglu B; Adsay V
Hum Pathol; 2023 Feb; 132():12-19. PubMed ID: 35934108
[TBL] [Abstract] [Full Text] [Related]
5. Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis.
Ng CW; Wong KK
J Ovarian Res; 2022 May; 15(1):63. PubMed ID: 35610648
[TBL] [Abstract] [Full Text] [Related]
6. High Expression of Bloom Syndrome Helicase is a Key Factor for Poor prognosis and Advanced Malignancy in Patients with Pancreatic cancer: A Retrospective Study.
Lan C; Yamashita YI; Hayashi H; Nakagawa S; Imai K; Mima K; Kaida T; Matsumoto T; Maruno M; Liu Z; Wu X; Wei F; Baba H
Ann Surg Oncol; 2022 Jun; 29(6):3551-3564. PubMed ID: 35419757
[TBL] [Abstract] [Full Text] [Related]
7. Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2.
Zhang F; Xu Y; Ye W; Jiang J; Wu C
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667627
[TBL] [Abstract] [Full Text] [Related]
8. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract] [Full Text] [Related]
9. Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas.
Kim YH; Kim JH
Endocrinol Metab (Seoul); 2019 Sep; 34(3):314-322. PubMed ID: 31565884
[TBL] [Abstract] [Full Text] [Related]
10. [Clinicopathological significance of Golgi phosphoprotein 3 expression in papillary thyroid carcinoma].
Huang DH; Jin L; Xie WW; Lin Q; Chen X
Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2831-2835. PubMed ID: 31550811
[No Abstract] [Full Text] [Related]
11. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract] [Full Text] [Related]
12. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
[TBL] [Abstract] [Full Text] [Related]
13. The Impact of Underweight Status on the prognosis of Ovarian cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract] [Full Text] [Related]
14. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
Zhang Q; Liu SZ; Zhang Q; Guan YX; Chen QJ; Zhu QY
Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894
[TBL] [Abstract] [Full Text] [Related]
15. Are Early Relapses in Advanced-Stage Ovarian cancer Doomed to a Poor prognosis?
Vidal F; Guerby P; Luyckx M; Haddad P; Stoeckle E; Morice P; Leblanc E; Lecuru F; Daraï E; Classe JM; Pomel C; Filleron T; Ferron G; Querleu D; Rafii A
PLoS One; 2016; 11(1):e0147787. PubMed ID: 26820579
[TBL] [Abstract] [Full Text] [Related]
16. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract] [Full Text] [Related]
17. Minimally invasive follicular carcinoma: predictors of vascular invasion and impact on patterns of care.
Goffredo P; Jillard C; Thomas S; Scheri RP; Sosa JA; Roman S
Endocrine; 2016 Jan; 51(1):123-30. PubMed ID: 26077949
[TBL] [Abstract] [Full Text] [Related]
18. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
[TBL] [Abstract] [Full Text] [Related]
19. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis.
Trimboli P; Treglia G; Guidobaldi L; Romanelli F; Nigri G; Valabrega S; Sadeghi R; Crescenzi A; Faquin WC; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2015 Feb; 82(2):280-5. PubMed ID: 25047365
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract] [Full Text] [Related]
[Next]
